LIANY · LianBio · Executive Compensation
Market Cap
$5.30M
Shares
108.06M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ehong Gu | Interim Chief Financial Officer | Appointed | 2023-12-20 |
| Yi Larson | Chief Financial Officer | Resigned | 2023-12-20 |
| Adam Stone | Interim Chief Executive Officer | Appointed | 2023-12-19 |
| Yizhe Wang | member of the Company's board of directors | Resigned | 2023-12-19 |
| Yizhe Wang | Chief Executive Officer | Resigned | 2023-12-19 |